Efficacy, safety and biomarkers of SG001 for patients with previously treated recurrent or metastatic cervical cancer: an open-label, multicenter, phase Ib trial
SG001治疗既往接受过治疗的复发性或转移性宫颈癌患者的疗效、安全性和生物标志物:一项开放标签、多中心、Ib期试验
期刊:Cancer Communications
影响因子:24.9
doi:10.1002/cac2.12578
Zuo, Jing; Duan, Wei; Zhao, Mingxuan; Chen, Zhendong; Lin, Jie; Shi, Huaqiu; Jiang, Ou; Zhang, Youzhong; Fang, Meiyu; Wang, Li; Wang, Wei; Huang, Yong; Yu, Junyan; Zhang, Xiaoxue; Pu, Weiqing; Hao, Deshun; She, Fenglin; Yang, Xiugao; Chen, Ying; Tang, Qizhi; Zhang, Xiao; Niu, Miao; Song, Yan'e; Wu, Lingying